Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion


Cinal A., Ziemssen F., Bartz-Schmidt K. U., Gelisken F.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, cilt.249, sa.4, ss.513-520, 2011 (SCI-Expanded) identifier identifier identifier

Özet

Purpose To report the long-term effect of intravitreal bevacizumab on serous macular detachment (SMD) in central retinal vein occlusion (CRVO).